Skip to content

Efficacy and Safety of Photodynamic Therapy for Chronic Exfoliative Cheilitis: A Randomized Controlled Clinical Trial

Efficacy and Safety of Photodynamic Therapy for Erosive Chronic Exfoliative Cheilitis: A Randomized Controlled Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123260
Enrollment
Unknown
Registered
2026-04-23
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic exfoliative cheilitis

Interventions

Experimental Group A:Photodynamic Therapy
Control group B:Triamcinolone acetonide

Sponsors

West China Hospital of Stomatology, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >=18 years, regardless of gender; 2. The lips are mainly characterized by exfoliation, which can be accompanied by local dry swelling, itching, tingling or burning pain. The condition is repeated and can last for months or even years. 3. Can clearly express their own symptoms and feelings; 4. Participants voluntarily participated in this study and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Those with other types of cheilitis such as actinic cheilitis or glandular cheilitis or contact cheilitis, and those with malignant tumors in the mouth or lips ; 2. Pregnancy or lactation; 3. In the past month, patients received systemic or local treatment for chronic desquamation cheilitis, including the use of glucocorticoids, calcineurin inhibitors, anti-infective drugs, etc. 4. Triamcinolone acetonide or laser, or photodynamic therapy history of allergy; 5. Participants with immune system dysfunction ( such as rheumatoid arthritis, systemic lupus erythematosus, HIV infection, etc. ) or who are using immunosuppressive agents ( such as cyclosporine, methotrexate, etc. ). 6. Participants who could not complete the follow-up of the study ( such as hospitalization, mental disorders, non-cooperation ) and other conditions that the researchers did not consider suitable for inclusion.

Design outcomes

Primary

MeasureTime frame
Healing Rate of Scale;Overall Response Rate, ORR;

Secondary

MeasureTime frame
Recurrence Rate;Adverse reaction incidence rate;quality of life;

Countries

China

Contacts

Public ContactZhou Hongmei

West China Hospital of Stomatology, Sichuan University

acomnet@126.com+86 28 85503480

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026